Apellis Pharmaceuticals, Inc. Common Stock
XNAS:APLS
21.2
$21.50 - 5.00
$20.70 - 1.00
$21
$21.38
$21.05
$21.3
35.72
16.1
1552520
2184203.3
103758218.03
Chart
TendieTensor AI Analysis
Company
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
Fundamentals
710
71.741327
6.716510
100
BBG007KGRPY4
BBG007KGRPZ3
126.29M
126.53M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own APLS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.